Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Human medicines
Medicines
Medicines
Marketing Authorisation procedures
Procedures

Procedures

Under construction. See other languages.

Last updated on 22/03/2016

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

23/08/2019

Recall of batches of COCUNE brand mitt-type body wipes

08/08/2019

Belgian Koenraad Norga elected as new chair of EMA’s Paediatric Committee

01/08/2019

Marketing authorization (MA) holders can now also use the FAMHP’s post box address in product information

31/07/2019

Is the electronic patient information leaflet just as effective as the paper version? e-PIL pilot project evaluation

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact